LINC02041

Across TCGA pan-cancer cohorts, LINC02041 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC02041’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02041 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02041 is over-expressed in tumor.

KIRC, HNSC, and BLCA are the cancer types where LINC02041 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02041 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+2.414	<.001	12	view →
HNSC	Male	All	+1.825	<.001	11	view →
BLCA	All	III,IV	+2.017	<.001	10	view →
LUAD	Female	II,III,IV	+1.565	<.001	7	view →
LIHC	All	All	+0.699	<.001	7	view →
LUSC	Female	II,III,IV	+2.755	<.001	6	view →
KICH	All	All	+1.745	<.001	6	view →
UCEC	All	All	+1.696	<.001	6	view →
CHOL	All	All	+3.888	<.001	5	view →
PAAD	All	All	+3.105	.004	4	view →
KIRP	Male	II,III,IV	+1.192	.022	3	view →
ESCA	All	II,III,IV	+2.929	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC02041–KIRC

Open the KIRC breakdown →